Liu Y - Search Results

1

Durvalumab-Induced Demyelinating Lesions in a Patient With Extensive-Stage Small-Cell Lung Cancer: A Case Report.

Liu W, Chen B, Liu Y, Luo Z, Sun B, Ma F. Liu W, et al. Among authors: liu y. Front Pharmacol. 2022 Jan 3;12:799728. doi: 10.3389/fphar.2021.799728. eCollection 2021. Front Pharmacol. 2022. PMID: 35046822 Free PMC article.

2

Intestinal Microbiome Associated With Immune-Related Adverse Events for Patients Treated With Anti-PD-1 Inhibitors, a Real-World Study.

Liu W, Ma F, Sun B, Liu Y, Tang H, Luo J, Chen H, Luo Z. Liu W, et al. Among authors: liu y. Front Immunol. 2021 Dec 16;12:756872. doi: 10.3389/fimmu.2021.756872. eCollection 2021. Front Immunol. 2021. PMID: 34975845 Free PMC article.

3

Vitamin D metabolism pathway polymorphisms are associated with efficacy and safety in patients under anti-PD-1 inhibitor therapy.

Luo J, Chen H, Ma F, Xiao C, Sun B, Liu Y, Tang H, Yang Y, Liu W, Luo Z. Luo J, et al. Among authors: liu y, liu w. Front Immunol. 2022 Sep 12;13:937476. doi: 10.3389/fimmu.2022.937476. eCollection 2022. Front Immunol. 2022. PMID: 36172344 Free PMC article.

4

Peripheral Blood Markers Associated with Immune-Related Adverse Effects in Patients Who Had Advanced Non-Small Cell Lung Cancer Treated with PD-1 Inhibitors.

Liu W, Liu Y, Ma F, Sun B, Wang Y, Luo J, Liu M, Luo Z. Liu W, et al. Among authors: liu y, liu m. Cancer Manag Res. 2021 Jan 27;13:765-771. doi: 10.2147/CMAR.S293200. eCollection 2021. Cancer Manag Res. 2021. PMID: 33536784 Free PMC article.

5

Gut microbiota: An intermediary between metabolic syndrome and cognitive deficits in schizophrenia.

Zeng C, Yang P, Cao T, Gu Y, Li N, Zhang B, Xu P, Liu Y, Luo Z, Cai H. Zeng C, et al. Among authors: liu y. Prog Neuropsychopharmacol Biol Psychiatry. 2021 Mar 2;106:110097. doi: 10.1016/j.pnpbp.2020.110097. Epub 2020 Sep 8. Prog Neuropsychopharmacol Biol Psychiatry. 2021. PMID: 32916223 Review.

6

Slow-Release H₂S Donor Anethole Dithiolethione Protects Liver From Lipotoxicity by Improving Fatty Acid Metabolism.

Zhao C, Yu N, Li W, Cai H, Liu M, Hu Y, Liu Y, Tang M. Zhao C, et al. Among authors: liu y, liu m. Front Pharmacol. 2020 Sep 23;11:549377. doi: 10.3389/fphar.2020.549377. eCollection 2020. Front Pharmacol. 2020. PMID: 33071780 Free PMC article.

7

Population Pharmacokinetics of Polymyxin B and Dosage Optimization in Renal Transplant Patients.

Li Y, Deng Y, Zhu ZY, Liu YP, Xu P, Li X, Xie YL, Yao HC, Yang L, Zhang BK, Zhou YG. Li Y, et al. Among authors: liu yp. Front Pharmacol. 2021 Aug 25;12:727170. doi: 10.3389/fphar.2021.727170. eCollection 2021. Front Pharmacol. 2021. PMID: 34512352 Free PMC article.

8

Complete Blood Count Score Model Predicts Inferior Prognosis in Primary Central Nervous System Lymphoma.

Feng Y, Liu Y, Zhong M, Wang L. Feng Y, et al. Among authors: liu y. Front Oncol. 2021 Mar 26;11:618694. doi: 10.3389/fonc.2021.618694. eCollection 2021. Front Oncol. 2021. PMID: 33842320 Free PMC article.

9

LncRNA VPS9D1-AS1 Promotes Malignant Progression of Lung Adenocarcinoma by Targeting miRNA-30a-5p/KIF11 Axis.

Liu J, Feng Y, Zeng X, He M, Gong Y, Liu Y. Liu J, et al. Among authors: liu y. Front Genet. 2022 Jan 24;12:807628. doi: 10.3389/fgene.2021.807628. eCollection 2021. Front Genet. 2022. PMID: 35140744 Free PMC article.

10

Metachronous triple primary neoplasms with primary prostate cancer, lung cancer, and colon cancer: A case report.

Feng Y, Zhong M, Zeng S, Xiao D, Liu Y. Feng Y, et al. Among authors: liu y. Medicine (Baltimore). 2018 Jun;97(26):e11332. doi: 10.1097/MD.0000000000011332. Medicine (Baltimore). 2018. PMID: 29953024 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

210,486 results

Search Page

Filters